| 17q21. 31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease and progressive supranuclear palsy converge on altered glial regulation KR Bowles, DA Pugh, K Farrell, N Han, J TCW, Y Liu, SA Liang, L Qian, ... BioRxiv, 860668, 2019 | 5 | 2019 |
| 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes KR Bowles, DA Pugh, Y Liu, T Patel, AE Renton, S Bandres-Ciga, ... Molecular neurodegeneration 17 (1), 48, 2022 | 30 | 2022 |
| 18 of Parkinson’s Disease K Senkevich, RN Alcalay, Z Gan-Or Non-motor Parkinson's Disease, 199, 2022 | | 2022 |
| 2.114 PERIPAPILLARY RETINAL NERVE FIBER LAYER THICKNESS IN PATIENTS WITH PARKINSON'S DISEASE, PATIENTS WITH DIFFERENT GENETICS STATUS T Gurevich, H Shabtai, E Naftaliev, M Neudorfer, Y Balash, E Rosenberg, ... Parkinsonism and Related Disorders, S105, 2012 | | 2012 |
| A 23 years follow-up study identifies GLUT1 deficiency syndrome initially diagnosed as complicated hereditary spastic paraplegia M Diomedi, Z Gan-Or, F Placidi, PA Dion, A Szuto, M Bengala, ... European Journal of Medical Genetics 59 (11), 564-568, 2016 | 12 | 2016 |
| A closer look into Parkinson’s Disease GWAS genes: Targeted next-generation sequencing approach U Rudakou McGill University (Canada), 2020 | | 2020 |
| A coding VPS13C haplotype is associated with reduced risk for Parkinson disease U Rudakou, J Ruskey, L Krohn, S Laurent, D Spiegelman, L Greenbaum, ... MOVEMENT DISORDERS 34, S191-S192, 2019 | | 2019 |
| A comprehensive analysis of dominant and recessive parkinsonism genes in REM sleep behavior disorder K Mufti, U Rudakou, E Yu, JA Ruskey, F Asayesh, SB Laurent, ... medRxiv, 2020.03. 17.20032664, 2020 | 3 | 2020 |
| A founder French-Canadian GBA mutation, p. W378G, as a cause for synucleinopathies and Gaucher disease Z Gan-Or, J Ruskey, S Zhou, L Ronciere, A Alam, D Spiegelman, ... MOVEMENT DISORDERS 33, S633-S633, 2018 | | 2018 |
| A homozygous mutation in SLC1A4 in siblings with severe intellectual disability and microcephaly M Srour, FF Hamdan, Z Gan‐Or, D Labuda, C Nassif, M Oskoui, ... Clinical genetics 88 (1), E1-E4, 2015 | 49 | 2015 |
| A mutation in HIP1R THATCH domain identified in a Parkinson disease affected patient reduced actin binding and slows transferrin uptake P Pietruszka, V Legendre-Guillemin, M Boudreault-Bouchard, G Rouleau, ... MOLECULAR BIOLOGY OF THE CELL 26, 2015 | | 2015 |
| A pathogenic variant in RAB32 causes autosomal dominant Parkinson’s disease and activates LRRK2 kinase EK Gustavsson, J Follett, J Trinh, SK Barodia, R Real, Z Liu, ... medRxiv, 2024 | 2 | 2024 |
| A specific SEPT14 haplotype is associated with a reduced risk for Parkinson's disease A Orr-Urtreger, L Rozenkrantz, Z Gan-Or, M Gana-Weisz, A Mirelman, ... MOVEMENT DISORDERS 28, S394-S394, 2013 | | 2013 |
| A voxel‐based morphometry and diffusion tensor imaging analysis of asymptomatic Parkinson's disease‐related G2019S LRRK2 mutation carriers A Thaler, M Artzi, A Mirelman, Y Jacob, RC Helmich, BFL van Nuenen, ... Movement Disorders 29 (6), 823-827, 2014 | 27 | 2014 |
| Advancing Parkinson's Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) Cohort M Cressatti, GD Pinilla-Monsalve, M Blais, CP Normandeau, C Degroot, ... medRxiv, 2024.05. 10.24307196, 2024 | | 2024 |
| Age at onset of Parkinson’s disease among Ashkenazi Jewish patients: contribution of environmental factors, LRRK2 p. G2019S and GBA p. N370S mutations G Yahalom, A Rigbi, S Israeli-Korn, L Krohn, U Rudakou, JA Ruskey, ... Journal of Parkinson's Disease 10 (3), 1123-1132, 2020 | 30 | 2020 |
| Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium K Marder, Y Wang, RN Alcalay, H Mejia-Santana, MX Tang, A Lee, ... Neurology 85 (1), 89-95, 2015 | 167 | 2015 |
| Alpha Galactosidase A Activity in Parkinson Disease (S45. 005) R Alcalay, O Levy, C Waters, S Fahn, B Ford, SH Kuo, ... Neurology 90 (15_supplement), S45. 005, 2018 | | 2018 |
| Alpha galactosidase A activity in Parkinson's disease RN Alcalay, P Wolf, OA Levy, UJ Kang, C Waters, S Fahn, B Ford, SH Kuo, ... Neurobiology of disease 112, 85-90, 2018 | 71 | 2018 |
| Alzheimer’s Disease Polygenic Risk Score Is Not Associated With Cognitive Decline Among Older Adults With Type 2 Diabetes SB Manzali, E Yu, R Ravona-Springer, A Livny, S Golan, Y Ouyang, ... Frontiers in Aging Neuroscience 14, 853695, 2022 | 2 | 2022 |
Guy RouleauMontreal Neurological Institute-Hospital, McGill UniversityVerified email at mcgill.ca
